Institutional investors purchased a net $11.3 million shares of INSM during the quarter ended September 2014 and now own 86.80% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MILLENNIUM MANAGEMENT LLC Bought 60.9 Thousand shares of Insmed Inc
REGENTATLANTIC CAPITAL LLC Bought 650.00 shares of Insmed Inc